- Regenerative Applications and Certification:
Success criteria and inoculation conditions for specific implementation are expected to vary from case to case. RevaTis is interested in defining these conditions for a wide variety of situations for both Human and Veterinary applications from undifferentiated stem cells.
Further improvement in the isolation and automation of the RevaTis patented process, as well as the development of novel applications and/or routes of administration will be considered with competent institutions.
In-vitro development of tissue cultures from stem cells provides unique opportunities to complement regenerative practices in hospital environments. Specialized laboratories with certified practices can offer their facilities to help develop, evaluate and test such techniques and grafting approaches.